IJCS | Volume 32, Nº5, September/October 2019

437 9. Remenyi B, et al. Improved long-term survival for rheumatic mitral valve repair compared to replacement in the young. World J Pediatr Congenit Heart Surg. 2013; 4:155–164. [PubMed: 23799728]. 10. Remenyi B, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline. Nat Rev Cardiol. 2012; 9:297–309. [PubMed: 22371105]. 11. Smeesters PR, McMillan DJ, Sriprakash KS, Georgousakis MM. Differences among group A streptococcus epidemiological landscapes: consequences for M protein- based vaccines? Expert Rev Vaccines 2009;8:1705–20. 12. Zuhlkel l, Karthikeyan DM, Engel ME etal. Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Lowand Middle-Income Countries Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation. 2016;134:1456– 1466. DOI: 10.1161/CIRCULATIONAHA.116.024769. 13. Mota CC, Meira ZM, Graciano RN, Graciano FF, Araujo FD. Rheumatic fever prevention program: long-term evolution and outcomes. Front Pediatr 2014;2:141. Soares AM Rheumatic Heart Disease - How are we in 2019, have we evolved? Int J Cardiovasc Sci. 2019;32(5):435-437 Editorial This is an open-access article distributed under the terms of the Creative Commons Attribution License